<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1">
<front>
<journal-meta>
<journal-id journal-id-type="pmc">IJFF</journal-id>
<journal-id journal-id-type="nlm-ta">IJFF</journal-id>
<journal-id journal-id-type="publisher-id">IJFF</journal-id>
<journal-title-group>
<journal-title>International Journal of Fermented Foods</journal-title>
</journal-title-group>
<issn pub-type="ppub">2319-3549</issn>
<issn pub-type="epub">2321-712X</issn>
<publisher>
<publisher-name>SASNET</publisher-name>
<publisher-loc>India</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="other">IJFF-09-02-31</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Paper</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Determination of <italic>In-Vitro</italic> Anticancer Activity and Short Chain Fatty Acids in Traditionally Fermented Millet Gruels</article-title>
</title-group>
<contrib-group><contrib contrib-type="author">
<name><surname>Kumar</surname><given-names>P. Praveen</given-names></name><xref ref-type="aff" rid="A1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001"><sup>*</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Begum</surname><given-names>V. Hazeena</given-names></name><xref ref-type="aff" rid="A2"><sup>2</sup></xref></contrib></contrib-group>
<aff id="A1"><label>1</label>Research Scholar, Department of Siddha Medicine, Faculty of Science, Tamil University, Thanjavur-613 010, India</aff>
<aff id="A2"><label>2</label>Professor &#x0026; Head, Department of Siddha Medicine, Faculty of Science, Tamil University, Thanjavur-613 010, India</aff>
<author-notes>
<corresp id="cor001">Corresponding author: <email>pravee.21msc@gmail.com</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year iso-8601-date="2020">2020</year>
</pub-date>
<volume>9</volume>
<issue>2</issue>
<fpage>31</fpage>
<lpage>35</lpage>
<history>
<date date-type="received" iso-8601-date="2020-08-16">
<day>16</day>
<month>08</month>
<year>2020</year>
</date>
<date date-type="revised" iso-8601-date="2020-11-17">
<day>17</day>
<month>11</month>
<year>2020</year>
</date>
<date date-type="accepted" iso-8601-date="2020-12-05">
<day>05</day>
<month>12</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; SASNET, India</copyright-statement>
<copyright-year>2020</copyright-year>
<copyright-holder>SASNET, India</copyright-holder>
</permissions>
<self-uri content-type="pdf" xlink:href="IJFF-09-02-31.pdf"></self-uri>
<abstract>
<p>The millets are called as nutricereals due to the availability of beneficial nutrients. The fermented millet gruels prepared from <italic>P. miliare</italic>, <italic>S. italica</italic>, <italic>P. scrobiculatum</italic> and <italic>E. frumantacea.</italic> and the millet gruels were analysed for the Short chain fatty acids (SCFA). The anticancer efficacy of the fermented millet gruels also investigated <italic>in vitro</italic> in the Human breast cancer cell line, MCF-7. <italic>P. miliare</italic> fermented gruel showed the acetic acid in the levels of 0.89 &#x00B5;M, lactic acid as 1.76 &#x00B5;M, propionic acid in the levels of 1.82 &#x00B5;M and butyric acids in the levels of 10.58 &#x00B5;M. The fermented <italic>S.italica</italic> gruel showed acetic, lactic and butyric acid levels of 1.12 &#x00B5;M, 2.41 &#x00B5;M and 42.85 &#x00B5;M respectively. The fermented <italic>P.scrobiculatum</italic> gruel showed the acetic acid of 1.04 &#x00B5;M, lactic acid of 0.89 &#x00B5;M, proponic acid of 2.26 &#x00B5;M and butyric acid of 3.09 &#x00B5;M. The fermented <italic>E. frumantacea</italic> also showed high levels of propionic acid (8.93 &#x00B5;M) and 2.7 &#x00B5;M of acetic acid. The anticancer efficacy also shown the <italic>S. italica</italic> fermented gruel have the high potential against the breast cancer cell line, MCF-7 compared to the other fermented millet gruel. It may be due to the high butyric acid content of the <italic>S. italica</italic> fermented gruel.</p>
</abstract>
<kwd-group>
<kwd>Millets</kwd>
<kwd>SCFA</kwd>
<kwd>anticancer activity</kwd>
<kwd>Butyric acid</kwd>
<kwd>MCF-7</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<ref-count count="10"/>
<page-count count="6"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1">
<title/>
<p>Millet is more than just an interesting alternative to the more common grains. The grain is also rich in phytochemicals, including phytic acid, which is believed to lower cholesterol, and phytate, which is associated with reduced cancer risk (<xref ref-type="bibr" rid="R2">Coulibaly <italic>et al</italic>. 2011</xref>). These health benefits have been partly attributed to the wide variety of potential chemopreventive substances, called phytochemicals, including antioxidants present in high amounts in foods such as millets (<xref ref-type="bibr" rid="R3">Izadi <italic>et al</italic>. 2012</xref>).</p>
<p>Breast cancer is now the most common cancer in Indian women, having recently overtaken cervical cancer in this respect. Earlier cervical cancer was most common cancer in Indian woman but now the incidence of breast cancer has surpassed cervical cancer and is leading cause of cancer death, although cervical cancer still remains most common in rural India (<xref ref-type="bibr" rid="R4">Kaarthigeyan, 2012</xref>).</p>
<p>Fermentation involves in the production of many nutraceutical products such as Short chain fatty acids (SCFA), antimicrobial agents, vitamins, etc. The fermentation of millets also produce many nutrients which will combat against many disorders. Millet&#x2019;s whole grain also shows prebiotic activity, which helps to increase the population of friendly bacteria that plays a key role to promote digestion. Malting induces important beneficial biochemical changes in the millet grain.</p>
<p><bold>How to cite this article:</bold> P. Praveen Kumar and V. Hazeena Begum (2020). Determination of <italic>In-Vitro</italic> Anticancer Activity and Short Chain Fatty Acids in Traditionally Fermented Millet Gruels. <italic>Intl. J. Ferment. Food,</italic> <bold>9</bold>(2):31-35.</p>
<p><bold>Source of Support:</bold> ICMR, New Delhi; <bold>Conflict of Interest:</bold> None</p>
<p>In the present study we are interested in searching food products which may reduce the severity of the deadly disorders such as breast cancer. Since the anticancer drugs are not afforded by many of the people in our country, a food source which could control the cancer severity will be beneficial to the poor people in India. The present study was carried out to investigate anticancer efficacy of the fermented minor millets against human breast cancer cell lines.</p>
</sec>
<sec id="S2">
<title>MATERIALS AND METHODS</title>
<sec id="S2_1">
<title>Preparation of fermented millet gruel</title>
<p>20g of the millet grains were cleaned and washed with potable water. 100ml of potable water was added and cooked well. Cooked meal was cooled to room temperature and 150ml of water was added. The mixture was fermented for overnight and the gruel was analyzed for propionic acid content by high performance thin layer chromatography (HPTLC) technique. The 1.0-ml fermented gruels were centrifuged for 5 min at 5000<italic>g</italic>. The resulting supernatants were then transferred to an eppendorf tube to perform the identification process of acetic, propionic, lactic and butyric acids. Prior to use, the samples were filtered through 0.45&#x03BC;m filter.</p>
</sec>
<sec id="S2_2">
<title>Determination of SCFA by HPTLC</title>
<p>A Camag HPTLC system equipped with an automatic TLC sampler, TLC scanner 3 and integrated software WINCATS version 1.4.1 was used for the analysis. Chromatrography was performed on 10 cm &#x00D7; 10 cm HPTLC plates coated with silica gel 60F 254 (E-Merck) of 200 &#x03BC;m layer thickness for the quantification of propionic acid. Standard and samples were applied to the plates as 8mm long bands, 8mm apart by use of a Camag Linomat(V) sample applicator equipped with a 10 &#x00B5;l microsyringe and an automatic TLC sampler under a flow of Nitrogen gas.</p>
<p>The linear ascending development was carried out in a Camag glass twin through chamber (20 cm &#x00D7; 10 cm) previously saturated with 20 mL mobile phase containing acetone: water: chloroform: ethanol: ammonium hydroxide (60:2:6:10:22) mixture (Lee <italic>et al</italic>., 2001) for 15 min at room temperature 25&#x00B0;C. Plates were developed to a distance of 80 mm. Subsequent to the development; the TLC plate was dried in a current of air with an air dryer. The TLC plates were then removed from the chamber and allowed to dry in air. The dried TLC plates were sprayed with the indicator solution, and the color was developed by brief heating (1&#x2013;3 min.) in a hot dry oven 165&#x00B0;C. Quantitative evaluation of the plate was performed in absorbance-reflectance mode at <italic>&#x03BB;</italic><sub>max</sub> =210 nm, using a slit width 6 &#x00D7; 0.4 mm, data resolution 100 mm Step - 1, scanning speed 20 mms<sup>-1</sup> and baseline correction was used.</p>
</sec>
<sec id="S2_3">
<title><italic>In vitro</italic> anticancer activity</title>
</sec>
<sec id="S2_4">
<title>Preparation of fermented millet gruel extract</title>
<p>The millets were cooked and cooled to room temperature. The cooked millets were added with 100 ml of potable water and fermented for overnight. The fermented gruels were extracted with Petroleum ether and Diethyl ether (1:1) and the solvents are evaporated and dried. The residues were reconstituted in DMSO for the in vitro anticancer assay.</p>
</sec>
<sec id="S2_5">
<title>Cell culture conditions</title>
<p>MCF-7 human breast carcinoma cell line was purchased from National Center for Cell Sciences (NCCS), Pune. The cell lines were grown at 37 &#x00B0;C in a 5% CO<sub>2</sub>, 95% air humidified atmosphere, in DMEM supplemented with 10% heat inactivated Fetal Bovine Serum (FBS) to which penicillin (100 U/mL) and streptomycin (100 &#x00B5;g g/ml) had been added.&#x00B5;/mL) and amphotericin B (5 The growth-inhibitory effect of L-glutaminase (freeze dried dialysed fractions) on the cancer cell lines was determined using a colorimetric test, MTT assay.</p>
<p>Cells were seeded in 96-well plates at a density of 5x10<sup>3</sup> cells per well in 100 &#x00B5;l of medium with FBS then cultured in a CO<sub>2</sub> incubator at 37 &#x00B0;C for 24 h. After which, 10 &#x03BC;l of fermented millet gruels (or 20 &#x00B5;l of DMEM medium with FBS for the control) was added to each well and the plate was incubated for 96 h. After incubation, 20 &#x03BC;l MTT stock solution (5 mg/ml in phosphate buffered saline or PBS, pH 7.5, filtered through 0.22-&#x03BC;m cellulose acetate filter; Sigma, St. Louis) was added to each well, incubated for 4 h at 37 &#x00B0;C then the solution was decanted. To stop succinate tetrazolium reductase activity and solubilise formazan crystals, 100 &#x00B5;L of propanol was then added to each well. Absorbance was read on a plate reader (VERS Amax, Molecular Devices, Saint Gregoire, France) at 540 nm. The percentage growth inhibition was calculated using the following formula and the concentration of enzyme extract needed to inhibit cell growth by 50% (CTC50) values is generated from the dose response curves for each cell line.</p>
</sec>
</sec>
<sec id="S3">
<title>RESULTS AND DISCUSSION</title>
<sec id="S3_1">
<title>SCFA Analysis by HPTLC</title>
<p>The fermented millet gruels showed different concentrations of short chain fatty acids such as acetic, propionic, butyric and lactic acids (<xref ref-type="table" rid="T1">Table 1</xref>). <italic>P. miliare</italic> fermented gruel showed the acetic acid in the levels of 0.89 &#x00B5;M, lactic acid as 1.76 &#x00B5;M, propionic acid in the levels of 1.82 &#x00B5;M and butyric acids in the levels of 10.58 &#x00B5;M. The fermented <italic>S.italica</italic> gruel showed acetic, lactic and butyric acid levels of 1.12 &#x00B5;M, 2.41 &#x00B5;M and 42.85 &#x00B5;M respectively. The fermented <italic>P. scrobiculatum</italic> gruel showed the acetic acid of 1.04 &#x00B5;M, lactic acid of 0.89 &#x00B5;M, proponic acid of 2.26 &#x00B5;M and butyric acid of 3.09 &#x00B5;M. The fermented <italic>E.frumantacea</italic> also showed high levels of propionic acid (8.93 &#x00B5;M) and 2.7 &#x00B5;M of acetic acid.</p>
</sec>
<sec id="S3_2">
<title>In-vitro anticancer activity</title>
<p>The effect of extracellular and intracellular extracts on the viability of cancer cells was determined by MTT (3[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide) assay on HeLa cells. The most active extracts were further screened on MCF-7 cells by MTT assay. The viability of the MCF-7 cells were determined by exposing cells to various concentrations of the fermented millet gruel (0.31 mg /mL, 0.62 mg /mL, 1.25 mg/mL and 2.5 mg/mL) for 72 h. The viability % was defined as the concentration of drug at which there was 50% less growth compared to control cells. Each experiment was performed in triplicate and is shown in the Tab (<xref ref-type="fig" rid="F1">Fig. 1</xref> to 4).</p>
<fig id="F1">
<label>Fig. 1</label>
<caption>
<p>Effect of Fermented <italic>Panicum miliare</italic> gruel extract on Breast cancer cell lines MCF-7</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJFF-09-02-31-f001.jpg"/>
</fig>
<table-wrap id="T1">
<label>Table 1</label>
<caption>
<p>SCFA content of fermented millet gruels by HPTLC</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJFF-09-02-31-t001.jpg"/>
</table-wrap>
<p>Results indicated that the extracts of <italic>Setaria italica</italic> fermented gruel and <italic>Panicum miliare</italic> gruels had promising anticancer activity against Breast cancer (MCF-7) cell lines. The <italic>S.italica</italic> gruel at a concentration of 2.5 mg/mL showed only 15.54% of growth compared to control on MCF-7 cells by the MTT method. The <italic>S. itailica</italic> extract showed 55.08 % growth of MCF-7 cells at the initial concentration of 0.31mg/mL and it gradually reduced to 15.54% growth which is more potential concentration of the drug against the MCF-7 breast cancer cell lines.</p>
<fig id="F2">
<label>Fig. 2</label>
<caption>
<p>Effect of Fermented <italic>Setaria italica</italic> gruel extract on Breast cancer cell lines MCF-7</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJFF-09-02-31-f002.jpg"/>
</fig>
<fig id="F3">
<label>Fig. 3</label>
<caption>
<p>Effect of Fermented <italic>Paspalum scrobiculatum</italic> gruel extract on Breast cancer cell lines MCF-7</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJFF-09-02-31-f003.jpg"/>
</fig>
<fig id="F4">
<label>Fig. 4</label>
<caption>
<p>Effect of Fermented <italic>Echinochloa frumantacea</italic> gruel extract on Breast cancer cell lines MCF-7</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IJFF-09-02-31-f004.jpg"/>
</fig>
<p><italic>Panicum miliare</italic> extract showed the inhibition of the growth of breast cancer cells at the concentration of 21.34% at the maximum of dosage of 2.5 mg/mL and the maximum viability of the cancer cells were observed at the concentration of 0.31mg/mL concentration of the millet gruel extract. The <italic>P. scrobiculatum</italic> showed only 67.69% of inhibition of the MCF-7 cell lines at the concentration of 0.31g/mL and it showed 37.28% growth at the maximum concentration of 2.5 g/mL, which is comparatively lower than the <italic>P. miliare</italic> and <italic>S. italica</italic> fermented gruel extracts.</p>
<p>The <italic>E. frumentace</italic> fermented gruel extract has not shown significant reduction in the growth of breast cancer cell line MCF-7 at the concentrations from 0.31mg/mL to 2.5 mg/mL. It showed the growth of the cancer cells from 59.32% to 60.31% which were significantly lower than the other fermented millet gruels. The <italic>S. italica</italic> showed more anticancer efficacy compared to other fermented gruels. It showed more butyric acid content of 42.85 &#x00B5;M. The high anticancer activity of <italic>S. italica</italic> fermented gruel may be the high contribution of butyric acid content.</p>
<p>In vivo studies have associated butyrate levels with a decreased incidence of colon cancer (<xref ref-type="bibr" rid="R6">Mcintyre <italic>et al.</italic> 1993</xref>; <xref ref-type="bibr" rid="R8">Okata <italic>et al.</italic> 1989</xref>), and butyrate instilled into the colonic lumen reduced tumor production in a chemical model of colon carcinogenesis (<xref ref-type="bibr" rid="R7">Medina <italic>et al.</italic> 1988</xref>). Although its precise mechanisms of action are not well understood, butyrate inhibits histone deacetylase (HDAC), resulting in a relative hyperacetylation of core histone proteins (H3 and H4) (<xref ref-type="bibr" rid="R9">Sealy &#x0026; Chalkley, 1978</xref>).</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<ref id="R1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Augeron</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Laboisse</surname>, <given-names>C.L.</given-names></string-name></person-group> <year>1984</year>. <article-title>Emergence of permanently differentiated cell clones in a human colonic cancer cell line after treatment with sodium butyrate</article-title>. <source>Cancer Res</source>., <volume>44</volume>: <fpage>3961</fpage>&#x2013;<lpage>3969</lpage>.</mixed-citation></ref>
<ref id="R2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coulibaly</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kouakou</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>J.</given-names></string-name></person-group> <year>2011</year>. <article-title>Phytic acid in cereal grains: structure, healthy or harmful ways to reduce phytic acid in cereal grains and their effects on nutritional quality</article-title>. <source>Am. J. Plant Nutr. Fert. Technol.,</source> <volume>1</volume>: <fpage>1</fpage>&#x2013;<lpage>22</lpage>.</mixed-citation></ref>
<ref id="R3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Izadi</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Nasirpour</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Izadi</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Izadi</surname>, <given-names>T.</given-names></string-name></person-group> <year>2012</year>. <article-title>Reducing blood cholesterol by a healthy diet</article-title>. <source>Int. Food Res. J.,</source> <volume>19</volume>(<issue>1</issue>):<fpage>29</fpage>&#x2013;<lpage>37</lpage>.</mixed-citation></ref>
<ref id="R4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaarthigeyan</surname>, <given-names>K.</given-names></string-name></person-group> <year>2012</year>. <article-title>Cervical cancer in India and HPV vaccination</article-title>. <source>Indian J. Med. Paediatr. Oncol.,</source> <volume>33</volume>: <fpage>7</fpage>&#x2013;<lpage>12</lpage>.</mixed-citation></ref>
<ref id="R5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname>, <given-names>K.Y.</given-names></string-name>, So. J.S. and <string-name><surname>Heo</surname>, <given-names>T.H.</given-names></string-name></person-group> <year>2001</year>. <article-title>Thin layer chromatographic determination of organic acids for rapid identification of bifidobacteria at genus level</article-title>. <source>J Microbiol. Meth.,</source> <volume>45</volume>: <fpage>1</fpage>-<lpage>6</lpage>.</mixed-citation></ref>
<ref id="R6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mcintyre</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gibson</surname>, <given-names>P.R.</given-names></string-name>, <string-name><surname>Young</surname>, <given-names>G.P.</given-names></string-name></person-group> <year>1993</year>. <article-title>Butyrate production from dietary fiber and protection against large bowel cancer in a rat model</article-title>. <source>Gut.,</source> <volume>34</volume>: <fpage>386</fpage>&#x2013;<lpage>391</lpage>.</mixed-citation></ref>
<ref id="R7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Medina</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Afonso</surname>, <given-names>J.J.</given-names></string-name>, <string-name><surname>Alvarez-Arguelles</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Hernandez</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gonzalez</surname>, <given-names>F.</given-names></string-name></person-group> <year>1988</year>. <article-title>Sodium butyrate inhibits carcinoma development in a 1,2- dimethylhydrazine-induced rat colon cancer</article-title>. <source>J. Parenter. Enteral. Nutr.,</source> <volume>22</volume>: <fpage>14</fpage>&#x2013;<lpage>17</lpage>.</mixed-citation></ref>
<ref id="R8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okata</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Singhal</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Hakomori</surname>, <given-names>S.</given-names></string-name></person-group> <year>1989</year>. <article-title>Antibodymediated targeting of differentiation inducers to tumor cells: inhibition of colonic cancer cell growth in vivo and in vitro</article-title>. <source>Biochem. Biophys. Res. Commun.,</source> <volume>158</volume>: <fpage>202</fpage>&#x2013;<lpage>208</lpage>.</mixed-citation></ref>
<ref id="R9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sealy</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Chalkley</surname>, <given-names>R.</given-names></string-name></person-group> <year>1978</year>. <article-title>The effect of sodium butyrate on histone modification</article-title>. <source>Cell,</source> <volume>14</volume>: <fpage>115</fpage>&#x2013;<lpage>121</lpage>.</mixed-citation></ref>
<ref id="R10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Whitehead</surname>, <given-names>R.H.</given-names></string-name>, <string-name><surname>Young</surname>, <given-names>G.P.</given-names></string-name>, <string-name><surname>Bhathal</surname>, <given-names>P.S.</given-names></string-name></person-group> <year>1986</year>. <article-title>Effects of short chain fatty acids on a new human colon carcinoma cell line (LIM 1215)</article-title>. <source>Gut.,</source> <volume>27</volume>: <fpage>1457</fpage>&#x2013;<lpage>1463</lpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>
